BlackRock Fund Advisors’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$6.65M Buy
6,824
+1,108
+19% +$993K ﹤0.01% 2788
2016
Q3
$4.97M Buy
5,716
+298
+6% +$234K ﹤0.01% 2847
2016
Q2
$3.97M Buy
5,418
+4,923
+995% +$3.37M ﹤0.01% 2936
2016
Q1
$281K Sell
495
-39
-7% -$20K ﹤0.01% 3358
2015
Q4
$304K Sell
534
-15
-3% -$7.48K ﹤0.01% 3386
2015
Q3
$219K Sell
549
-14
-2% -$6.63K ﹤0.01% 3433
2015
Q2
$304K Buy
563
+67
+14% +$33.9K ﹤0.01% 3364
2015
Q1
$242K Sell
496
-33
-6% -$16.4K ﹤0.01% 3435
2014
Q4
$287K Buy
529
+38
+8% +$19.5K ﹤0.01% 3381
2014
Q3
$262K Sell
491
-36
-7% -$18.8K ﹤0.01% 3377
2014
Q2
$223K Buy
527
+15
+3% +$6.78K ﹤0.01% 3453
2014
Q1
$281K Buy
512
+62
+14% +$36.2K ﹤0.01% 3373
2013
Q4
$251K Buy
450
+19
+4% +$11.3K ﹤0.01% 3371
2013
Q3
$272K Buy
431
+63
+17% +$36.1K ﹤0.01% 3294
2013
Q2
$175K Buy
+368
New +$182K ﹤0.01% 3367

Other funds holding ALT

BlackRock Fund Advisors's ALT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Altimmune (ALT) stake by 19% in Q4 2016, buying an estimated $993K and bringing the position to 6,824 shares worth $6.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2788.

BlackRock Fund Advisors first reported a position in ALT in Q2 2013 and has held it in 15 quarters since. 88 funds tracked by Wall St. Rank hold ALT as of Q4 2016.

  • BlackRock Fund Advisors held 6,824 shares of Altimmune worth $6.65M as of Q4 2016.
  • BlackRock Fund Advisors bought 1,108 Altimmune shares in Q4 2016, an estimated $993K.
  • Altimmune made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2788 holding.
  • BlackRock Fund Advisors first reported a position in Altimmune in Q2 2013 and has held it in 15 quarters since.
  • 88 funds tracked by Wall St. Rank held Altimmune as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.